Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Ironwood Pharmaceuticals stock | $11.57

Learn how to easily invest in Ironwood Pharmaceuticals stock.

Ironwood Pharmaceuticals, Inc is a drug manufacturers-specialty & generic business based in the US. Ironwood Pharmaceuticals shares (IRWD) are listed on the NASDAQ and all prices are listed in US Dollars. Ironwood Pharmaceuticals employs 232 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Ironwood Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – IRWD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Ironwood Pharmaceuticals stock price (NASDAQ: IRWD)

Use our graph to track the performance of IRWD stocks over time.

Ironwood Pharmaceuticals shares at a glance

Information last updated 2021-07-30.
Latest market close$11.57
52-week range$8.63 - $13.65
50-day moving average $12.49
200-day moving average $11.24
Wall St. target price$12.67
PE ratio 14.9438
Dividend yield N/A (0%)
Earnings per share (TTM) $0.89

Buy Ironwood Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Ironwood Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ironwood Pharmaceuticals price performance over time

Historical closes compared with the close of $11.57 from 2021-05-28

1 week (2021-07-23) N/A
1 month (2021-07-02) -8.03%
3 months (2021-05-03) 4.23%
6 months (2021-01-30) N/A
1 year (2020-07-30) N/A
2 years (2019-07-30) N/A
3 years (2018-07-30) N/A
5 years (2016-07-30) N/A

Is Ironwood Pharmaceuticals under- or over-valued?

Valuing Ironwood Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Ironwood Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Ironwood Pharmaceuticals's P/E ratio

Ironwood Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Ironwood Pharmaceuticals shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Ironwood Pharmaceuticals's EBITDA

Ironwood Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $193.5 million.

The EBITDA is a measure of a Ironwood Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Ironwood Pharmaceuticals financials

Revenue TTM $398.4 million
Operating margin TTM 48.04%
Gross profit TTM $298.3 million
Return on assets TTM 23.85%
Return on equity TTM 0%
Profit margin 35.83%
Book value $0.68
Market capitalisation $2.2 billion

TTM: trailing 12 months

Shorting Ironwood Pharmaceuticals shares

There are currently 19.6 million Ironwood Pharmaceuticals shares held short by investors – that's known as Ironwood Pharmaceuticals's "short interest". This figure is 1.9% down from 19.9 million last month.

There are a few different ways that this level of interest in shorting Ironwood Pharmaceuticals shares can be evaluated.

Ironwood Pharmaceuticals's "short interest ratio" (SIR)

Ironwood Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ironwood Pharmaceuticals shares currently shorted divided by the average quantity of Ironwood Pharmaceuticals shares traded daily (recently around 2.1 million). Ironwood Pharmaceuticals's SIR currently stands at 9.36. In other words for every 100,000 Ironwood Pharmaceuticals shares traded daily on the market, roughly 9360 shares are currently held short.

However Ironwood Pharmaceuticals's short interest can also be evaluated against the total number of Ironwood Pharmaceuticals shares, or, against the total number of tradable Ironwood Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ironwood Pharmaceuticals's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Ironwood Pharmaceuticals shares in existence, roughly 120 shares are currently held short) or 0.1368% of the tradable shares (for every 100,000 tradable Ironwood Pharmaceuticals shares, roughly 137 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Ironwood Pharmaceuticals.

Find out more about how you can short Ironwood Pharmaceuticals stock.

Ironwood Pharmaceuticals share dividends

We're not expecting Ironwood Pharmaceuticals to pay a dividend over the next 12 months.

Have Ironwood Pharmaceuticals's shares ever split?

Ironwood Pharmaceuticals's shares were split on a 1194:1000 basis on 1 April 2019. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1194 shares. This wouldn't directly have changed the overall worth of your Ironwood Pharmaceuticals shares – just the quantity. However, indirectly, the new 16.2% lower share price could have impacted the market appetite for Ironwood Pharmaceuticals shares which in turn could have impacted Ironwood Pharmaceuticals's share price.

Ironwood Pharmaceuticals share price volatility

Over the last 12 months, Ironwood Pharmaceuticals's shares have ranged in value from as little as $8.63 up to $13.65. A popular way to gauge a stock's volatility is its "beta".

IRWD.US volatility(beta: 1.34)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ironwood Pharmaceuticals's is 1.3406. This would suggest that Ironwood Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Ironwood Pharmaceuticals overview

Ironwood Pharmaceuticals, Inc. , a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist, which is in pre-clinical development for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis. It has strategic partnerships with AbbVie Inc. , AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide.

Stocks similar to Ironwood Pharmaceuticals

Frequently asked questions

What percentage of Ironwood Pharmaceuticals is owned by insiders or institutions?
Currently 1.373% of Ironwood Pharmaceuticals shares are held by insiders and 108.933% by institutions.
How many people work for Ironwood Pharmaceuticals?
Latest data suggests 232 work at Ironwood Pharmaceuticals.
When does the fiscal year end for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals's fiscal year ends in December.
Where is Ironwood Pharmaceuticals based?
Ironwood Pharmaceuticals's address is: 100 Summer Street, Boston, MA, United States, 02110
What is Ironwood Pharmaceuticals's ISIN number?
Ironwood Pharmaceuticals's international securities identification number is: US46333X1081
What is Ironwood Pharmaceuticals's CUSIP number?
Ironwood Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 46333X108

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site